136 related articles for article (PubMed ID: 28417251)
21. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
[TBL] [Abstract][Full Text] [Related]
22. Comparison between cryoablation and irreversible electroporation of rabbit livers at a location close to the gallbladder.
Zeng J; Qin Z; Zhou L; Fang G; Chen J; Li J; Niu L; Liang B; Xu K
Radiol Oncol; 2017 Mar; 51(1):40-46. PubMed ID: 28265231
[TBL] [Abstract][Full Text] [Related]
23. Irreversible electroporation ablation of the liver can be detected with ultrasound B-mode and elastography.
Au JT; Kingham TP; Jun K; Haddad D; Gholami S; Mojica K; Monette S; Ezell P; Fong Y
Surgery; 2013 Jun; 153(6):787-93. PubMed ID: 23489942
[TBL] [Abstract][Full Text] [Related]
24. Irreversible electroporation for the ablation of liver tumors: are we there yet?
Charpentier KP
Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
[TBL] [Abstract][Full Text] [Related]
25. Early Differentiation of Irreversible Electroporation Ablation Regions With Radiomics Features of Conventional MRI.
Eresen A; Sun C; Zhou K; Shangguan J; Wang B; Pan L; Hu S; Ma Q; Yang J; Zhang Z; Yaghmai V
Acad Radiol; 2022 Sep; 29(9):1378-1386. PubMed ID: 34933803
[TBL] [Abstract][Full Text] [Related]
26. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
[TBL] [Abstract][Full Text] [Related]
27. Electrochemical Effects after Transarterial Chemoembolization in Combination with Percutaneous Irreversible Electroporation: Observations in an Acute Porcine Liver Model.
Vollherbst D; Bertheau RC; Fritz S; Mogler C; Kauczor HU; Ryschich E; Radeleff BA; Pereira PL; Sommer CM
J Vasc Interv Radiol; 2016 Jun; 27(6):913-921.e2. PubMed ID: 27103147
[TBL] [Abstract][Full Text] [Related]
28. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
[TBL] [Abstract][Full Text] [Related]
29. Irreversible electroporation attenuates neointimal formation after angioplasty.
Maor E; Ivorra A; Leor J; Rubinsky B
IEEE Trans Biomed Eng; 2008 Sep; 55(9):2268-74. PubMed ID: 18713696
[TBL] [Abstract][Full Text] [Related]
30. Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model.
Deodhar A; Monette S; Single GW; Hamilton WC; Thornton R; Maybody M; Coleman JA; Solomon SB
Urology; 2011 Mar; 77(3):754-60. PubMed ID: 21111458
[TBL] [Abstract][Full Text] [Related]
31. Assessment of various types of US findings after irreversible electroporation in porcine liver: comparison with radiofrequency ablation.
Sugimoto K; Moriyasu F; Kobayashi Y; Kasuya K; Nagakawa Y; Tsuchida A; Hara T; Iobe H; Oshiro H
J Vasc Interv Radiol; 2015 Feb; 26(2):279-87.e3. PubMed ID: 25645416
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the therapeutic efficacy of sequential therapy involving percutaneous microwave ablation in combination with 131I-hypericin using the VX2 rabbit breast solid tumor model.
Zhu M; Lin XA; Zha XM; Zhou WB; Xia TS; Wang S
PLoS One; 2015; 10(3):e0120303. PubMed ID: 25799220
[TBL] [Abstract][Full Text] [Related]
33. Development of an Electroporation and Nanoparticle-based Therapeutic Platform for Bone Metastases.
Melancon MP; Appleton Figueira T; Fuentes DT; Tian L; Qiao Y; Gu J; Gagea M; Ensor JE; Muñoz NM; Maldonado KL; Dixon K; McWatters A; Mitchell J; McArthur M; Gupta S; Tam AL
Radiology; 2018 Jan; 286(1):149-157. PubMed ID: 28825892
[TBL] [Abstract][Full Text] [Related]
34. Irreversible electroporation of the porcine kidney: Temperature development and distribution.
Wagstaff PG; de Bruin DM; van den Bos W; Ingels A; van Gemert MJ; Zondervan PJ; Verdaasdonk RM; van Lienden KP; van Leeuwen TG; de la Rosette JJ; Laguna Pes MP
Urol Oncol; 2015 Apr; 33(4):168.e1-7. PubMed ID: 25557146
[TBL] [Abstract][Full Text] [Related]
35. Electric Ablation with Irreversible Electroporation (IRE) in Vital Hepatic Structures and Follow-up Investigation.
Chen X; Ren Z; Zhu T; Zhang X; Peng Z; Xie H; Zhou L; Yin S; Sun J; Zheng S
Sci Rep; 2015 Nov; 5():16233. PubMed ID: 26549662
[TBL] [Abstract][Full Text] [Related]
36. Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas.
Rossmeisl JH; Garcia PA; Pancotto TE; Robertson JL; Henao-Guerrero N; Neal RE; Ellis TL; Davalos RV
J Neurosurg; 2015 Oct; 123(4):1008-25. PubMed ID: 26140483
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous Irreversible Electroporation as First-line Treatment of Locally Advanced Pancreatic Cancer.
Månsson C; Brahmstaedt R; Nygren P; Nilsson A; Urdzik J; Karlson BM
Anticancer Res; 2019 May; 39(5):2509-2512. PubMed ID: 31092446
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Irreversible Electroporation on the Femur: Experimental Study in a Rabbit Model.
Song Y; Zheng J; Yan M; Ding W; Xu K; Fan Q; Li Z
Sci Rep; 2015 Dec; 5():18187. PubMed ID: 26655843
[TBL] [Abstract][Full Text] [Related]
39. Imaging Intratumoral Nanoparticle Uptake After Combining Nanoembolization with Various Ablative Therapies in Hepatic VX2 Rabbit Tumors.
Tam AL; Melancon MP; Abdelsalam M; Figueira TA; Dixon K; McWatters A; Zhou M; Huang Q; Mawlawi O; Dunner K; Li C; Gupta S
J Biomed Nanotechnol; 2016 Feb; 12(2):296-307. PubMed ID: 27305763
[TBL] [Abstract][Full Text] [Related]
40. Tumor Ablation Enhancement by Combining Radiofrequency Ablation and Irreversible Electroporation: An In Vitro 3D Tumor Study.
Zhang B; Yang Y; Ding L; Moser MAJ; Zhang EM; Zhang W
Ann Biomed Eng; 2019 Mar; 47(3):694-705. PubMed ID: 30565007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
